Xeris Biopharma Holdings Inc (XERS)
2.24
-0.02
(-0.88%)
USD |
NASDAQ |
Jun 28, 16:00
2.245
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Cash from Financing (Quarterly): 35.19M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 35.19M |
| December 31, 2023 | -1.234M |
| September 30, 2023 | -0.072M |
| June 30, 2023 | 0.556M |
| March 31, 2023 | -0.863M |
| December 31, 2022 | 49.16M |
| September 30, 2022 | -0.187M |
| June 30, 2022 | 0.31M |
| March 31, 2022 | 78.19M |
| December 31, 2021 | 0.125M |
| September 30, 2021 | 0.001M |
| June 30, 2021 | 0.46M |
| March 31, 2021 | 26.66M |
| December 31, 2020 | 3.326M |
| September 30, 2020 | 13.06M |
| Date | Value |
|---|---|
| June 30, 2020 | 69.61M |
| March 31, 2020 | 40.07M |
| December 31, 2019 | 1.97M |
| September 30, 2019 | 22.57M |
| June 30, 2019 | -0.157M |
| March 31, 2019 | 56.15M |
| December 31, 2018 | 0.029M |
| September 30, 2018 | 13.18M |
| June 30, 2018 | 90.80M |
| March 31, 2018 | 24.20M |
| December 31, 2017 | 5.467M |
| September 30, 2017 | 0.019M |
| June 30, 2017 | 30.02M |
| March 31, 2017 | -0.368M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.234M
Minimum
Dec 2023
78.19M
Maximum
Mar 2022
17.84M
Average
1.97M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| AVITA Medical Inc | 0.631M |
| INmune Bio Inc | -2.50M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.30M |
| Cash from Investing (Quarterly) | -19.65M |
| Free Cash Flow | -43.38M |
| Free Cash Flow Per Share (Quarterly) | -0.1457 |
| Free Cash Flow to Equity (Quarterly) | -59.21M |
| Free Cash Flow to Firm (Quarterly) | -15.27M |
| Free Cash Flow Yield | -13.98% |